ImmunologybioRxivPreprint
Soquelitinb, A selective inhibitor of interleukin-2-inducible kinase (ITK), is active in several murine models of T cell-mediated inflammatory disease
Lih‐Yun Hsu, James Todd Rosenbaum, Sarah Lindner…·Richard A. Miller
This study shows that soquelitinib inhibits ITK and reduces T cell-mediated inflammation in multiple murine models.
1 citation